Stay updated on HEC585 Safety & PK in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the HEC585 Safety & PK in Healthy Subjects Clinical Trial page.

Latest updates to the HEC585 Safety & PK in Healthy Subjects Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions for the idiopathic pulmonary fibrosis treatment drug HEC585 and the addition of a new revision number.SummaryDifference33%
- Check34 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check70 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check92 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to HEC585 Safety & PK in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HEC585 Safety & PK in Healthy Subjects Clinical Trial page.